Ra Pharmaceuticals, Inc. (7)
Browse by Contract Category
Contracts
-
Second Amendment to Lease Agreement, dated March 11, 2020, by and between Ra Pharmaceuticals, Inc. and HCP/King 87 CPD LLC
(Filed With SEC on March 16, 2020)
-
Description of Capital Stock
(Filed With SEC on February 27, 2020)
-
License Agreement, dated as of July 15, 2019, by and between the Registrant and Camurus AB
(Filed With SEC on November 7, 2019)
-
Agreement and Plan of Merger, dated October 9, 2019, by and among UCB S.A., Franq Merger Sub, Inc. and Ra Pharmaceuticals, Inc
(Filed With SEC on October 10, 2019)
-
Non-Employee Director Compensation Policy, effective April 1, 2019
(Filed With SEC on August 7, 2019)
-
Open Market Sale AgreementSM, dated as of May 9, 2019, by and between Ra Pharmaceuticals, Inc. and Jefferies LLC
(Filed With SEC on May 9, 2019)
-
Underwriting Agreement, dated July 23, 2019, between the Company and Jefferies LLC, BMO Capital Markets Corp. and Stifel, Nicolaus & Company, Incorporated, as representatives of...
(Filed With SEC on July 26, 2019)